Payment overview · 2025
General Payments
$18.33
1 reported records · 1 companies
Healthcare provider profile · identity verified
David Lawrence Herman, M.D.
Allopathic & Osteopathic Physicians|Internal Medicine · COHOES, NY · NPI 1073505723
Verified facts
What the public records show
CMS Open Payments records show David Lawrence Herman, M.D. received $18.33 in general payments during 2025 across 1 reported records.
Aimmune Therapeutics, Inc. accounted for 100.0% of that reported general-payment amount.
The Open Payments records used for this analysis explicitly named 1 associated product.
These records do not establish that a payment influenced prescribing or medical care.
Separate record types
Research & Ownership
Research Payments (direct recipient): not present in the loaded data
Associated Research Funding (for example, named PI): not present in the loaded data
Ownership / Investment: not present in the loaded data
These categories are never added into the General Payments headline. Associated research funding must not be described as money the doctor personally received unless the source record supports that conclusion.
Who paid this doctor?
Companies in 2025 General Payments
| Reported company | Canonical company | Amount | Share | Records | Year |
|---|---|---|---|---|---|
| Aimmune Therapeutics, Inc. | Unresolved — no canonical attribution shown | $18.33 | 100.0% | 1 | 2025 |
What were the payments for?
Payment categories
| Category | Amount | Records |
|---|---|---|
| Food and Beverage | $18.33 | 1 |
A meal, consulting fee, royalty, and travel payment describe different kinds of reported relationships and should not be interpreted as equivalent.
Analysis 1 · Payment-linked products
Products named in Open Payments records
| Reported product | Type | Reported company | Related amount* | Records | Year |
|---|---|---|---|---|---|
| VOWST Normalized: vowst |
Biological | Aimmune Therapeutics, Inc. | $18.33 | 1 | 2025 |
Source payment records
|
|||||
* Product-associated amounts are non-additive because one payment record may name more than one product.
These products were named on specific Open Payments records. A named product does not show that the payment influenced treatment or prescribing.
Public prescribing for products named in payments
No exact normalized or approved-alias overlap was found in the loaded Part D year. This does not mean the doctor never prescribed the product.
The presence of the same drug in both datasets does not show that a payment caused or influenced a prescription.
Analysis 2 · Same-company prescribing overlap
Drugs reported in other payments from the same company that also appear in Medicare Part D
This analysis is independent from products named on this doctor’s individual payment records. A row appears only when the exact Open Payments reporting entity paid this doctor, that same reporting entity reported the drug or biological on at least 10 loaded General Payment records involving at least 2 distinct recipient NPIs, and this doctor has the same non-generic brand in public Part D data. This does not mean the company owns or manufactures the drug.
No publishable same-company prescribing overlap was found in the loaded Part D year. This does not mean the doctor never prescribed a drug reported elsewhere by a paying company.
These facts do not show that a payment was for the drug, that the company owns or manufactures the drug, or that a payment caused or influenced prescribing.
Public Medicare Part D data
Provider-and-drug rows loaded for 2024
| Brand | Generic | Claims | Beneficiaries |
|---|---|---|---|
| Atorvastatin Calcium | Atorvastatin Calcium | 388 | 49 |
| Levothyroxine Sodium | Levothyroxine Sodium | 384 | 39 |
| Pantoprazole Sodium | Pantoprazole Sodium | 315 | 42 |
| Gabapentin | Gabapentin | 265 | 35 |
| Eliquis | Apixaban | 246 | 31 |
| Amlodipine Besylate | Amlodipine Besylate | 228 | 29 |
| Rosuvastatin Calcium | Rosuvastatin Calcium | 219 | 28 |
| Metoprolol Succinate | Metoprolol Succinate | 197 | 34 |
| Losartan Potassium | Losartan Potassium | 188 | 23 |
| Furosemide | Furosemide | 183 | 27 |
| Lisinopril | Lisinopril | 181 | 21 |
| Escitalopram Oxalate | Escitalopram Oxalate | 154 | 20 |
| Omeprazole | Omeprazole | 144 | 17 |
| Potassium Chloride | Potassium Chloride | 130 | 17 |
| Clopidogrel | Clopidogrel Bisulfate | 126 | 16 |
| Spironolactone | Spironolactone | 124 | 19 |
| Sertraline Hcl | Sertraline Hcl | 120 | 20 |
| Simvastatin | Simvastatin | 114 | 12 |
| Dapagliflozin | Dapagliflozin Propanediol | 113 | 14 |
| Metoprolol Tartrate | Metoprolol Tartrate | 104 | 13 |
| Bumetanide | Bumetanide | 103 | 16 |
| Buspirone Hcl | Buspirone Hcl | 99 | 12 |
| Famotidine | Famotidine | 99 | 15 |
| Tamsulosin Hcl | Tamsulosin Hcl | 92 | 12 |
| Albuterol Sulfate Hfa | Albuterol Sulfate | 87 | 23 |
| Gemtesa | Vibegron | 79 | suppressed |
| Trazodone Hcl | Trazodone Hcl | 79 | suppressed |
| Trelegy Ellipta | Fluticasone/Umeclidin/Vilanter | 78 | suppressed |
| Allopurinol | Allopurinol | 76 | suppressed |
| Quetiapine Fumarate | Quetiapine Fumarate | 76 | suppressed |
| Glipizide Er | Glipizide | 75 | suppressed |
| Xarelto | Rivaroxaban | 75 | suppressed |
| Mounjaro | Tirzepatide | 74 | 11 |
| Ezetimibe | Ezetimibe | 72 | suppressed |
| Donepezil Hcl | Donepezil Hcl | 69 | 13 |
| Metformin Hcl Er | Metformin Hcl | 68 | suppressed |
| Ropinirole Hcl | Ropinirole Hcl | 67 | suppressed |
| Levetiracetam | Levetiracetam | 65 | suppressed |
| Metformin Hcl | Metformin Hcl | 62 | suppressed |
| Torsemide | Torsemide | 61 | suppressed |
| Hydralazine Hcl | Hydralazine Hcl | 60 | suppressed |
| Carvedilol | Carvedilol | 57 | suppressed |
| Pravastatin Sodium | Pravastatin Sodium | 54 | suppressed |
| Carbidopa-Levodopa | Carbidopa/Levodopa | 51 | suppressed |
| Hydrochlorothiazide | Hydrochlorothiazide | 49 | suppressed |
| Mirabegron Er | Mirabegron | 49 | suppressed |
| Montelukast Sodium | Montelukast Sodium | 49 | suppressed |
| Diltiazem 24hr Er (Cd) | Diltiazem Hcl | 48 | suppressed |
| Fluticasone-Vilanterol | Fluticasone/Vilanterol | 48 | suppressed |
| Fluticasone Propionate | Fluticasone Propionate | 45 | 13 |
| Fluticasone-Salmeterol | Fluticasone Propion/Salmeterol | 45 | suppressed |
| Latanoprost | Latanoprost | 44 | suppressed |
| Trulicity | Dulaglutide | 43 | suppressed |
| Bupropion Xl | Bupropion Hcl | 42 | suppressed |
| Insulin Aspart Flexpen | Insulin Aspart | 42 | suppressed |
| Citalopram Hbr | Citalopram Hydrobromide | 41 | suppressed |
| Myrbetriq | Mirabegron | 41 | suppressed |
| Olanzapine | Olanzapine | 40 | suppressed |
| Oxybutynin Chloride Er | Oxybutynin Chloride | 39 | suppressed |
| Alendronate Sodium | Alendronate Sodium | 36 | suppressed |
| Entresto | Sacubitril/Valsartan | 34 | suppressed |
| Insulin Glargine-Yfgn | Insulin Glargine-Yfgn | 31 | suppressed |
| Nifedipine Er | Nifedipine | 31 | suppressed |
| Tizanidine Hcl | Tizanidine Hcl | 31 | 12 |
| Aripiprazole | Aripiprazole | 30 | suppressed |
| Prednisone | Prednisone | 30 | suppressed |
| Tradjenta | Linagliptin | 30 | suppressed |
| Finasteride | Finasteride | 29 | suppressed |
| Lumigan | Bimatoprost | 29 | suppressed |
| Nortriptyline Hcl | Nortriptyline Hcl | 29 | suppressed |
| Venlafaxine Hcl Er | Venlafaxine Hcl | 29 | suppressed |
| Amiodarone Hcl | Amiodarone Hcl | 27 | suppressed |
| Ranolazine Er | Ranolazine | 27 | suppressed |
| Divalproex Sodium | Divalproex Sodium | 26 | suppressed |
| Raloxifene Hcl | Raloxifene Hcl | 26 | suppressed |
| Trospium Chloride | Trospium Chloride | 26 | suppressed |
| Lamotrigine | Lamotrigine | 25 | suppressed |
| Mirtazapine | Mirtazapine | 25 | suppressed |
| Hydrocodone-Acetaminophen | Hydrocodone/Acetaminophen | 24 | suppressed |
| Topiramate | Topiramate | 24 | suppressed |
| Belsomra | Suvorexant | 23 | suppressed |
| Hydroxyzine Pamoate | Hydroxyzine Pamoate | 23 | suppressed |
| Insulin Lispro Kwikpen U-100 | Insulin Lispro | 23 | suppressed |
| Brilinta | Ticagrelor | 22 | suppressed |
| Creon | Lipase/Protease/Amylase | 22 | suppressed |
| Hydroxychloroquine Sulfate | Hydroxychloroquine Sulfate | 22 | suppressed |
| Baclofen | Baclofen | 21 | suppressed |
| Fluoxetine Hcl | Fluoxetine Hcl | 21 | suppressed |
| Metformin Er Osmotic | Metformin Hcl | 21 | suppressed |
| Sucralfate | Sucralfate | 21 | suppressed |
| Amitriptyline Hcl | Amitriptyline Hcl | 20 | suppressed |
| Carbidopa-Levodopa Er | Carbidopa/Levodopa | 20 | suppressed |
| Valsartan | Valsartan | 20 | suppressed |
| Verapamil Er | Verapamil Hcl | 20 | suppressed |
| Autoshield Duo Pen Needle | Pen Needle,dual Safety,diabetc | 19 | suppressed |
| Breztri Aerosphere | Budesonide/Glycopyr/Formoterol | 19 | suppressed |
| Doxepin Hcl | Doxepin Hcl | 19 | suppressed |
| Dalfampridine Er | Dalfampridine | 18 | suppressed |
| Loperamide | Loperamide Hcl | 18 | suppressed |
| Midodrine Hcl | Midodrine Hcl | 18 | suppressed |
| Tramadol Hcl-Acetaminophen | Tramadol Hcl/Acetaminophen | 18 | suppressed |
| Celecoxib | Celecoxib | 17 | suppressed |
| Jardiance | Empagliflozin | 17 | suppressed |
| Methenamine Hippurate | Methenamine Hippurate | 17 | suppressed |
| Ozempic | Semaglutide | 17 | suppressed |
| Tresiba Flextouch U-100 | Insulin Degludec | 17 | suppressed |
| Acetazolamide Er | Acetazolamide | 16 | suppressed |
| Alprazolam | Alprazolam | 16 | suppressed |
| Budesonide-Formoterol Fumarate | Budesonide/Formoterol Fumarate | 16 | suppressed |
| Bupropion Hcl Sr | Bupropion Hcl | 16 | suppressed |
| Irbesartan | Irbesartan | 16 | suppressed |
| Ondansetron Hcl | Ondansetron Hcl | 16 | suppressed |
| Brimonidine Tartrate | Brimonidine Tartrate | 15 | suppressed |
| Brimonidine Tartrate-Timolol | Brimonidine Tartrate/Timolol | 15 | suppressed |
| Restasis Multidose | Cyclosporine | 15 | suppressed |
| Solifenacin Succinate | Solifenacin Succinate | 15 | suppressed |
| Tramadol Hcl | Tramadol Hcl | 15 | suppressed |
| Alogliptin | Alogliptin Benzoate | 14 | suppressed |
| Fenofibrate | Fenofibrate Nanocrystallized | 14 | suppressed |
| Isosorbide Dinitrate | Isosorbide Dinitrate | 14 | suppressed |
| Janumet | Sitagliptin Phos/Metformin Hcl | 14 | suppressed |
| Memantine Hcl | Memantine Hcl | 14 | suppressed |
| Pramipexole Dihydrochloride | Pramipexole Di-Hcl | 14 | suppressed |
| Sulfamethoxazole-Trimethoprim | Sulfamethoxazole/Trimethoprim | 14 | suppressed |
| Synthroid | Levothyroxine Sodium | 14 | suppressed |
| Bupropion Hcl | Bupropion Hcl | 13 | suppressed |
| Darunavir | Darunavir | 13 | suppressed |
| Diltiazem Hcl | Diltiazem Hcl | 13 | suppressed |
| Dulera | Mometasone/Formoterol | 13 | suppressed |
| Duloxetine Hcl | Duloxetine Hcl | 13 | suppressed |
| Dutasteride | Dutasteride | 13 | suppressed |
| Icosapent Ethyl | Icosapent Ethyl | 13 | suppressed |
| Imipramine Hcl | Imipramine Hcl | 13 | suppressed |
| Lantus Solostar | Insulin Glargine,hum.Rec.Anlog | 13 | suppressed |
| Letrozole | Letrozole | 13 | suppressed |
| Losartan-Hydrochlorothiazide | Losartan/Hydrochlorothiazide | 13 | suppressed |
| Metoclopramide Hcl | Metoclopramide Hcl | 13 | suppressed |
| Risperidone | Risperidone | 13 | suppressed |
| Rizatriptan | Rizatriptan Benzoate | 13 | suppressed |
| Roflumilast | Roflumilast | 13 | suppressed |
| Tegretol | Carbamazepine | 13 | suppressed |
| Terazosin Hcl | Terazosin Hcl | 13 | suppressed |
| Toujeo Solostar | Insulin Glargine,hum.Rec.Anlog | 13 | suppressed |
| Azithromycin | Azithromycin | 12 | suppressed |
| Bethanechol Chloride | Bethanechol Chloride | 12 | suppressed |
| Calcitriol | Calcitriol | 12 | suppressed |
| Emgality Syringe | Galcanezumab-Gnlm | 12 | suppressed |
| Isentress | Raltegravir Potassium | 12 | suppressed |
| Kapspargo Sprinkle | Metoprolol Succinate | 12 | suppressed |
| Lurasidone Hcl | Lurasidone Hcl | 12 | suppressed |
| Meloxicam | Meloxicam | 12 | suppressed |
| Methylprednisolone | Methylprednisolone | 12 | suppressed |
| Novofine Autocover | Pen Needle, Diabetic, Safety | 12 | suppressed |
| Ritonavir | Ritonavir | 12 | suppressed |
| Ultra-Fine Mini Pen Needle | Pen Needle, Diabetic | 12 | suppressed |
| Venlafaxine Hcl | Venlafaxine Hcl | 12 | suppressed |
| Zolpidem Tartrate | Zolpidem Tartrate | 12 | suppressed |
| Budesonide Er | Budesonide | 11 | suppressed |
| Dorzolamide Hcl | Dorzolamide Hcl | 11 | suppressed |
| Etravirine | Etravirine | 11 | suppressed |
| Farxiga | Dapagliflozin Propanediol | 11 | suppressed |
| Lyumjev Kwikpen U-200 | Insulin Lispro-Aabc | 11 | suppressed |
| Nitroglycerin | Nitroglycerin | 11 | suppressed |
| Ondansetron Odt | Ondansetron | 11 | suppressed |
| Oseltamivir Phosphate | Oseltamivir Phosphate | 11 | 11 |
| Paroxetine Hcl | Paroxetine Hcl | 11 | suppressed |
| Primidone | Primidone | 11 | suppressed |
| Propranolol Hcl Er | Propranolol Hcl | 11 | suppressed |
| Soaanz | Torsemide | 11 | suppressed |
| Toujeo Max Solostar | Insulin Glargine,hum.Rec.Anlog | 11 | suppressed |
| Travoprost | Travoprost | 11 | suppressed |
| Triamterene-Hydrochlorothiazid | Triamterene/Hydrochlorothiazid | 11 | suppressed |
| Verapamil Sr | Verapamil Hcl | 11 | suppressed |
Timeline
Payment and prescribing data by year
Open Payments and Medicare Part D may refer to different years. They are shown separately rather than aligned as if they describe the same period.
| Year | General Payments | Main payer | Explicit products | Company overlaps | Part D coverage |
|---|---|---|---|---|---|
| 2025 | $18.33 · 1 records | Aimmune Therapeutics, Inc. | VOWST | — | — |
| 2024 | — | — | — | — | Complete |
Questions to ask
Questions you could discuss with your doctor
- Are there reasonable alternatives I should understand when we discuss treatment options?
- How should I interpret the industry-payment records shown here in the context of my care?
These are general questions generated from reviewed templates. They are not personalized medical advice.
Sources and limitations
How to read this page
- Payment and Medicare prescribing data can cover different years; every comparison shows both years explicitly.
- Part D does not represent a doctor’s entire practice; it excludes many patients and is subject to CMS public-release thresholds.
- Company–drug relationships must have an auditable source, a precise relationship type, and a valid evidence period. Unresolved mappings are not published.
- Generic drug claims are not attributed to a specific manufacturer without manufacturer-level evidence.
- When a source extract is incomplete, missing rows are never treated as proof of no payments or no prescriptions.
Loaded source releases
| Dataset | Year | Publication | Source |
|---|---|---|---|
| CMS Open Payments — General Payments | 2025 | 2026-06-30 | Original source |
| Medicare Part D Prescribers by Provider and Drug | 2024 | 2026-05-06 | Original source |
| NPPES Data Dissemination V2 | current / reference data | 2026-08-10 | Original source |
Full methodology · Questions & answers · Report a possible error